Brain activation by peptide Pro-Leu-Gly- NH 2 (MIF-1)

International Journal of Peptides

Volumn 2010, Issue , 2010, Pages

  Khan, Reas S ^a   Yu, Chuanhui ^a   Kastin, Abba J ^a   He, Yi ^a   Ehrensing, Rudolph H ^b   Hsuchou, Hung ^a   Stone, Kirsten Prufer ^a   Pan, Weihong ^a  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^b OCHSNER CLINIC FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; PROLYLLEUCYLGLYCINAMIDE; PROTEIN C FOS; STAT3 PROTEIN;

ANIMAL EXPERIMENT; ANXIETY; ARTICLE; BRAIN MAPPING; BRAIN REGION; CONTROLLED STUDY; DEPRESSION; DOSE RESPONSE; DRUG ACTIVITY; FEMALE; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; MALE; MEMORY; MOOD; MOUSE; NERVE CELL CULTURE; NEUROANATOMY; NONHUMAN; ONCOGENE C FOS; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

EID: 84866430964     PISSN: 16879767     EISSN: 16879775     Source Type: Journal    
DOI: 10.1155/2010/537639     Document Type: Article

References (45)

1. Pan W., Kastin A. J., From MIF-1 to endomorphin: the Tyr-MIF-1 family of peptides Peptides 2007 28 12 2411 2434 (Pubitemid 350116318)
2. Xu D., Preliminary report on the effect of PLG (MIF-1) in the treatment of Parkinsons disease Acta Universitatis Medicinalis Secondae Shanghai 1986 6 328 329
3. Pan W., Kastin A. J., Shioda S., Homma I., Kato N., Evolution of neuropeptide concepts illustrated by MIF-1 and MSH Transmitters and Modulators in Health and Disease 2009 New York, NY, USA Springer 3 17 New Frontiers in Neuroscience
4. Kastin A. J., Hahn K., Erchegyi J., Differential metabolism of Tyr-MIF-1 and MIF-1 in rat and human plasma Biochemical Pharmacology 1994 47 4 699 709 (Pubitemid 24094275)
5. Kastin A. J., Olson R. D., Ehrensing R. H., Berzas M. C., Schally A. V., Coy D. H., MIF-Is differential actions as an opiate antagonist Pharmacology Biochemistry Behavior 1979 11 6 721 723 (Pubitemid 10143878)
6. Ehrensing R. H., Kastin A. J., Michell G. F., Antagonism of morphine analgesia by prolyl-leucyl-glycinamide (MIF-1) in humans Pharmacology Biochemistry Behavior 1984 21 6 975 978 (Pubitemid 15150754)
7. Plotnikoff N. P., Kastin A. J., Pharmacological studies with a tripeptide, prolyl leucyl glycine amide Archives Internationales de Pharmacodynamie et de Thérapie 1974 211 2 211 224
8. Barbeau A., Potentiation of levodopa effect by intravenous L prolyl L leucyl glycine amide in man Lancet 1975 2 7937 683 684
9. Srivastava L. K., Bajwa S. B., Johnson R. L., Mishra R. K., Interaction of L-prolyl-L-leucyl glycinamide with dopamine D2 receptor: evidence for modulation of agonist affinity states in bovine striatal membranes Journal of Neurochemistry 1988 50 3 960 968 (Pubitemid 18060429)
10. Miller L. G., Kastin A. J., MIF-1 and Tyr-MIF-1 do not alter GABA binding on the GABAa receptor Brain Research Bulletin 1990 25 6 917 918
11. Gulati A., Bhargava H. N., Effect of melanotropin release inhibiting factor on changes by haloperidol and centbutindole in cerebral cortical 5-hydroxytryptamine receptors Pharmacology 1990 41 2 98 106 (Pubitemid 20330154)
12. Pucilowski O., Plaznik A., Kostowski W., MIF-1 facilitates passive avoidance retention Polish Journal of Pharmacology and Pharmacy 1982 34 13 107 113 (Pubitemid 13173130)
13. Spirtes M. A., Christensen C. W., Harston C. T., Kastin A. J., -MSH and MIF-I effects on cGMP levels in various rat brain regions Brain Research 1978 144 1 189 193 (Pubitemid 8297923)
14. Morgan J. I., Curran T., Stimulus-transcription coupling in the nervous system: involvement of the inducible proto-oncogenes fos and jun Annual Review of Neuroscience 1991 14 421 451
15. Chen R.-H., Juo P. C.-H., Curran T., Blenis J., Phosphorylation of c-Fos at the C-terminus enhances its transforming activity Oncogene 1996 12 7 1493 1502 (Pubitemid 26132036)
16. Banks W. A., Kastin A. J., Opposite direction of transport across the blood-brain barrier for Tyr-MIF-1 and MIF-1: comparison with morphine Peptides 1994 15 1 23 29 (Pubitemid 24082568)
17. Kovcs K. J., Measurement of immediate-early gene activation- c- fos and beyond Journal of Neuroendocrinology 2008 20 6 665 672
18. Kovcs K. J., c-Fos as a transcription factor: a stressful (re)view from a functional map Neurochemistry International 1998 33 4 287 297
19. Abbott N. J., Kastin A. J., Pan W., Cellular composition of the blood-brain barrier The Blood-Brain Barrier: Understanding the Regulatory Gatekeeper between Brain and Body 2008 London, UK The Biomedical Life Sciences Collection The Henry Stewart Talk Series
20. Szirmai I., Kovcs T., Parkinson syndrome and cognitive disorders Ideggygyszati Szemle 2002 55 7-8 220 225
21. Vann S. D., Brown M. W., Erichsen J. T., Aggleton J. P., Using Fos imaging in the rat to reveal the anatomical extent of the disruptive effects of fornix lesions The Journal of Neuroscience 2000 20 21 8144 8152
22. Vergnes M., Lesions of the cingular cortex, behavior in the open-field and interspecific aggression behavior in rats Comptes Rendus des Séances de la Société de Biologie et de Ses Filiales 1972 166 6 933 935
23. El-Shenawy S. M., Abdel-Salam O. M. E., Baiuomy A. R., El-Batran S., Arbid M. S., Studies on the anti-inflammatory and anti-nociceptive effects of melatonin in the rat Pharmacological Research 2002 46 3 235 243 (Pubitemid 35300762)
24. Weil Z. M., Hotchkiss A. K., Gatien M. L., Pieke-Dahl S., Nelson R. J., Melatonin receptor (MT1) knockout mice display depression-like behaviors and deficits in sensorimotor gating Brain Research Bulletin 2006 68 6 425 429 (Pubitemid 43177577)
25. Kastin A. J., Viosca S., Nair R. M., Shally A. V., Miller M. C., Interactions between pineal, hypothalamus, and pituitary involving melatonin, MSH release-inhibiting factor and MSH Endocrinology 1972 91 5 1323 1328
26. OConnor D. H., Fukui M. M., Pinsk M. A., Kastner S., Attention modulates responses in the human lateral geniculate nucleus Nature Neuroscience 2002 5 11 1203 1209 (Pubitemid 35247180)
27. Beckwith B. E., Sandman C. A., Kastin A. J., Influence of three short-chain peptides ( -MSH, MSH/ACTH 4-10, MIF-I on) dimensional attention Pharmacology, Biochemistry Behavior 1976 5 supplement 1 11 16
28. Vidal-Gonzalez I., Vidal-Gonzalez B., Rauch S. L., Quirk G. J., Microstimulation reveals opposing influences of prelimbic and infralimbic cortex on the expression of conditioned fear Learning and Memory 2006 13 6 728 733 (Pubitemid 44871673)
29. Quirk G. J., Mueller D., Neural mechanisms of extinction learning and retrieval Neuropsychopharmacology 2008 33 1 56 72 (Pubitemid 350191313)
30. Hefner K., Whittle N., Juhasz J., Impaired fear extinction learning and cortico-amygdala circuit abnormalities in a common genetic mouse strain The Journal of Neuroscience 2008 28 32 8074 8085
31. Stratton L. O., Kastin A. J., Increased acquisition of a complex appetitive task after MSH and MIF Pharmacology Biochemistry Behavior 1975 3 5 901 904
32. Robertson G. S., Fibiger H. C., Neuroleptics increase c-fos expression in the forebrain: contrasting effects of haloperidol and clozapine Neuroscience 1992 46 2 315 328
33. Ehrensing R. H., Kastin A. J., Melanocyte-stimulating hormone-release inhibiting hormone as a antidepressant. A pilot study Archives of General Psychiatry 1974 30 1 63 65
34. Ehrensing R. H., Kastin A. J., Dose-related biphasic effect of prolyl-leucyl-glycinamide (MIF-I) in depression The American Journal of Psychiatry 1978 135 5 562 566 (Pubitemid 8329025)
35. van der Velde C. D., Rapid clinical effectiveness of MIF-I in the treatment of major depressive illness Peptides 1983 4 3 297 300
36. Moghaddam B., Bunney B. S., Acute effects of typical and atypical antipsychotic drugs on the release of dopamine from prefrontal cortex, nucleus accumbens, and striatum of the rat: an in vivo microdialysis study Journal of Neurochemistry 1990 54 5 1755 1760
37. Zornoza T., Cano-Cebrin M. J., Martnez-Garca F., Polache A., Granero L., Hippocampal dopamine receptors modulate cFos expression in the rat nucleus accumbens evoked by chemical stimulation of the ventral hippocampus Neuropharmacology 2005 49 7 1067 1076 (Pubitemid 41503305)
38. Ceccatelli S., Villar M. J., Goldstein M., Hokfelt T., Expression of c-Fos immunoreactivity in transmitter-characterized neurons after stress Proceedings of the National Academy of Sciences of the United States of America 1989 86 23 9569 9573 (Pubitemid 20010469)
39. Rivest S., Torres G., Rivier C., Differential effects of central and peripheral injection of interleukin-1 on brain c-fos expression and neuroendocrine functions Brain Research 1992 587 1 13 23
40. Hagan M. M., Moss D. E., Differential effects of Tyr-MIF-1, MIF-1, and naloxone on peptide YY-induced hyperphagia Peptides 1994 15 2 243 245 (Pubitemid 24113699)
41. Fendt M., Fanselow M. S., The neuroanatomical and neurochemical basis of conditioned fear Neuroscience and Biobehavioral Reviews 1999 23 5 743 760 (Pubitemid 29282023)
42. Beck C. H. M., Fibiger H. C., Conditioned fear-induced changes in behavior and in the expression of the immediate early gene c-fos: with and without diazepam pretreatment The Journal of Neuroscience 1995 15 1 709 720
43. Fukunaga H., Takahashi M., Kaneto H., Yoshikawa M., Effects of Tyr-MIF-1 on stress-induced analgesia and the blockade of development of morphine tolerance by stress in mice Japanese Journal of Pharmacology 1999 79 2 231 235 (Pubitemid 29140013)
44. Hichami A., Datiche F., Ullah S., Olfactory discrimination ability and brain expression of c-fos, Gir and Glut1 mRNA are altered in n-3 fatty acid-depleted rats Behavioural Brain Research 2007 184 1 1 10 (Pubitemid 47404648)
45. Hlinak Z., Krejci I., Social recognition in male rats: age differences and modulation by MIF-I and alaptide Physiological Research 1991 40 1 59 67